AGENAgenus Inc.
What is the market doing?
No clear lean: nothing decisive, though a crowded short (+15% of shares).
Choppy, but holding above its 200-day average. Oversold (RSI 22). Price is +30% vs its 200-day average.
A crowded short, settled Sep 30, 2026, about a week of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AGEN is trading
Agenus Inc. is +56% over the past year while the S&P 500 is +16%: 40 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +30%
vs 200-day average · a clear uptrend
- RSI (14)
- 22
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 36%
Below its 52-week high
Details›
- Last close2026-10-23
- $6.33
- 1 monthS&P 500 −0.94%
- −26%
- 1 yearS&P 500 +16%
- +56%
- 5 yearsS&P 500 +86%
- −94%
- vs 50-day average$7.66
- −17%
- 52-week high
- $9.93
- 52-week low
- $2.77
- Annualised volatility
- 111%
| Year | Return |
|---|---|
| 2026 (year to date) | +101% |
| 2025 | +15% |
| 2024 | −83% |
| 2023 | −65% |
| 2022 | −25% |
| 2021 | +1.3% |
| 2020 | −22% |
| 2019 | +71% |
| 2018 | −27% |
| 2017 | −21% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +6.1% |
| Feb | 10 | 4 of 10 | −0.77% |
| Mar | 10 | 1 of 10 | −16% |
| Apr | 10 | 6 of 10 | +6.7% |
| May | 10 | 5 of 10 | +9.8% |
| Jun | 10 | 8 of 10 | +8.3% |
| Jul | 11 | 5 of 11 | +10% |
| Aug | 11 | 7 of 11 | +5.0% |
| Sep | 11 | 4 of 11 | −1.3% |
| Oct | 11 | 3 of 11 | −17% |
| Nov | 10 | 7 of 10 | +11% |
| Dec | 10 | 2 of 10 | −8.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.